Cargando…
Primary antiphospholipid syndrome during aromatase inhibitors therapy: A case report and review of the literature
RATIONALE: Aromatase inhibitors (AIs) are a class of drugs widely used in the treatment of estrogen sensitive breast and ovarian cancer which convert testosterone to estradiol and androstenedione to estrogen. The AIs of third generation, including anastrazole, letrozole and exemestane, have actually...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455664/ https://www.ncbi.nlm.nih.gov/pubmed/30921233 http://dx.doi.org/10.1097/MD.0000000000015052 |